By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


UCB, Inc. 

1950 Lake Park Drive

Smyrna  Georgia  30080  U.S.A.
Phone: 770-437-5705 Fax: 770-437-5640



The Medicines Company  Contract manufacturing of Bivalirudin peptide active ingredient

Praecis Pharmaceuticals Incorporated  Contract manufacturing of Abarelix peptide active ingredient

Bausch & Lomb  Contract manufacturing of active pharmaceutical ingredient

Company News
UCB, Inc. (UCBJF.PK) Release: Results From CRIB Study On CIMZIA (Certolizumab Pegol) Demonstrate Minimal To No Placental Transfer Of Drug From Mother To Infant During Third Trimester Of Pregnancy 6/14/2017 7:19:49 AM
UCB, Inc. (UCBJF.PK) Selects Medidata Solutions, Inc. Clinical Cloud To Support Patient-Centric Drug Development 4/26/2017 6:28:41 AM
1CellBiO Announces Collaboration Agreement With UCB, Inc. (UCBJF.PK) 4/11/2017 9:04:57 AM
Argentum Persists In Challenging The "Evergreening" Patent On UCB, Inc. (UCBJF.PK)'s VIMPAT 3/24/2017 6:59:53 AM
UCB, Inc. (UCBJF.PK) Release: First CIMZIA (Certolizumab Pegol) Study Of Its Kind Showed Minimal To No Transfer Of Drug From Mother's Plasma To Breast Milk 3/6/2017 7:48:35 AM
Amgen (AMGN) And UCB, Inc. (UCBJF.PK) Announce Submission Of Application For Investigational Osteoporosis Medication Romosozumab In Japan 12/20/2016 9:13:10 AM
UCB, Inc. (UCBJF.PK) Release: The Lancet Publishes First Head-To-Head Study Of CIMZIA (Certolizumab Pegol) And Humira (Adalimumab) In Bio-Na├»ve Rheumatoid Arthritis Patients 11/15/2016 10:22:38 AM
MRC Technology, UCB, Inc. (UCBJF.PK) And University of Leicester Collaborate To Form Antibody-Assisted Structure-Based Drug Discovery Consortium 11/8/2016 10:31:36 AM
UCB, Inc. (UCBJF.PK) Release: Certolizumab pegol (Cimzia) AutoClicks Prefilled Pen - A New Self-Injection Device Designed In Collaboration With Patients And Good Grips - Is Now Available In The UK On The NHS[1] 10/25/2016 9:18:41 AM
Evotec AG (EVTG.F) And UCB, Inc. (UCBJF.PK) Sign Multi-Year CNS Pharmacology Agreement 10/20/2016 1:28:19 PM